Towards Healthcare Research & Consulting
Non-Small Lung Carcinoma Market
Updated Date: 21 April 2026   |   Report Code: 5155
[email protected] +1 804-441-9344
Download Sample Order Now

Non-Small Lung Carcinoma Market Size, Trends, Bridging Innovation and Accessibility

Market insights predict the global non-small lung carcinoma industry will increase from USD 9.1 billion in 2024 to USD 23.67 billion by 2034, achieving a CAGR of 10.03%. Clinical research, development of new treatment options, and prevalence of NSCLC is driving the growth of the market.

Last Updated : 21 April 2026 Category: Therapeutic Area Insight Code: 5155 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Non-Small Lung Carcinoma Market Assessment

  • Overview
  • Global Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Squamous Cell Carcinoma
    • Large Cell Carcinoma
    • Adenocarcinoma
    • Others
  • Global Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
    • Chemotherapy
    • Targeted Therapy
    • Immunotherapy
  • Global Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Pharmacy
  • Global Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Region (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

North America Non-Small Lung Carcinoma Market Assessment

  • Overview
  • North America Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Squamous Cell Carcinoma
    • Large Cell Carcinoma
    • Adenocarcinoma
    • Others
  • North America Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
    • Chemotherapy
    • Targeted Therapy
    • Immunotherapy
  • North America Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Pharmacy

Europe Non-Small Lung Carcinoma Market Assessment

  • Overview
  • Europe Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Squamous Cell Carcinoma
    • Large Cell Carcinoma
    • Adenocarcinoma
    • Others
  • Europe Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
    • Chemotherapy
    • Targeted Therapy
    • Immunotherapy
  • Europe Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Pharmacy

Asia Pacific Non-Small Lung Carcinoma Market Assessment

  • Overview
  • Asia Pacific Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Squamous Cell Carcinoma
    • Large Cell Carcinoma
    • Adenocarcinoma
    • Others
  • Asia Pacific Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
    • Chemotherapy
    • Targeted Therapy
    • Immunotherapy
  • Asia Pacific Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Pharmacy

Latin America Non-Small Lung Carcinoma Market Assessment

  • Overview
  • Latin America Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Squamous Cell Carcinoma
    • Large Cell Carcinoma
    • Adenocarcinoma
    • Others
  • Latin America Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
    • Chemotherapy
    • Targeted Therapy
    • Immunotherapy
  • Latin America Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Pharmacy

Middle East & Africa Non-Small Lung Carcinoma Market Assessment

  • Overview
  • Middle East & Africa Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Squamous Cell Carcinoma
    • Large Cell Carcinoma
    • Adenocarcinoma
    • Others
  • Middle East & Africa Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
    • Chemotherapy
    • Targeted Therapy
    • Immunotherapy
  • Middle East & Africa Non-Small Lung Carcinoma Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Pharmacy

Company Profiles

  • Eli Lilly and Company
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Celgene Corporation
  • AstraZeneca
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Sanofi, Merck & Co., Inc.
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Boehringer Ingelheim

Conclusion & Recommendations

FAQ's

Answer : Surgery, radiation therapy, chemoradiation therapy, combination therapy, targeted therapy, immunotherapy, systemic therapy, chemotherapy, adjuvant therapy.

Answer : Coughing that gets worse with time, coughing up blood, loss of appetite, fatigue, weight loss, wheezing, chest pain, trouble swallowing, face swelling, hoarseness and trouble breathing.

Answer : World Health Organization, Government of Canada, Centers for Disease Control and Prevention, National Cancer Institute, FDA, American Lung Association, and American Cancer Society.
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar